MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic
Interventions: DRUG: MCLA-128|DRUG: Trastuzumab|DRUG: Vinorelbine|DRUG: Endocrine therapy
Sponsor: Merus N.V.